Regulation of HIV by T-Cell Signal Transduction

T 细胞信号转导对 HIV 的调节

• 批准号: 7060900
• 负责人: Andrew J Henderson
• 金额: $ 27.79万
• 依托单位: PENNSYLVANIA STATE UNIVERSITY, THE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-05-01 至 2009-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7060900
• 关键词: CD28 molecule; T cell receptor; alkaline phosphatase; cell line; cell population study; chimeric proteins; clinical research; complementary DNA; genetic regulatory element; genetic transcription; host organism interaction; human immunodeficiency virus 1; human subject; leukocyte activation /transformation; molecular cloning; nucleic acid repetitive sequence; tissue /cell culture; transcription factor; virus genetics; virus infection mechanism; virus protein

DESCRIPTION (provided by applicant): T cell activation through the T cell receptor and costimulatory molecules such as CD28 has been demonstrated to influence the susceptibility of T cells to HIV-1 infection and regulate proviral transcription. However, the signaling events initiated by the T cell receptor complex and CD28 that /directly impact HIV-1 transcription have not been explored. In particular, it is unclear how CD28 signaling potentially enhances and inhibits HIV-1 expression. The objective this project is to determine the mechanisms by which CD28 regulates HIV-1 transcription, and to examine the interaction between HIV-1 Nef and CD28 signals. We hypothesize that CD28 engagement results in distinct signaling cascades that have very different consequences for HIV-1 expression and that the HIV-1 encoded protein Nef contributes to aberrant T cell signaling and function by interacting with different components of the CD28 signaling cascade. Our preliminary data using chimeric CD28 receptors that include mutations in critical tyrosine residues as well as inhibitors that block specific signal transduction pathways supports such a model. Furthermore, these initial experiments demonstrate phophatidylinositol-3-kinase inhibits H IV-1 transcription by a Tat-dependent mechanism. We are proposing to extend these studies and use cell lines, primary systems and biochemical approaches to 1) further characterize the role of differential signals from CD28 in regulating HIV-1 transcription, 2) characterize cis-elements and transcription factors that mediate induction of LTR activity in response to CD28 signals and 3) determine if Nef directly or indirectly alters CD28 signaling. Understanding the mechanisms by which CD28 regulates HIV-1 transcription will further define pathways associated with this receptor as well as identify putative upstream signal transduction events critical for controlling HIV-1 expression. Furthermore, the ability to manipulate these pathways may provide unique therapeutic targets for controlling virus expression. Relevance of this research to public health: We are proposing to identify and characterize cellular events that influence the production of HIV. Manipulating these cellular pathways may provide novel strategies that would complement current treatments to control HIV as well as approaches to purge latent HIV reserviors.

描述（由申请人提供）：已证明通过T细胞受体和共刺激分子（如CD 28）激活T细胞可影响T细胞对HIV-1感染的易感性并调节前病毒转录。然而，由T细胞受体复合物和CD 28启动的直接影响HIV-1转录的信号传导事件尚未被探索。特别是，目前还不清楚CD 28信号如何潜在地增强和抑制HIV-1表达。本项目的目的是确定CD 28调节HIV-1转录的机制，并研究HIV-1 Nef和CD 28信号之间的相互作用。我们假设CD 28参与导致不同的信号级联，这些信号级联对HIV-1表达具有非常不同的后果，并且HIV-1编码的蛋白Nef通过与CD 28信号级联的不同组分相互作用而导致异常的T细胞信号和功能。我们的初步数据使用嵌合CD 28受体，包括突变的关键酪氨酸残基，以及抑制剂，阻止特定的信号转导途径支持这样一个模型。此外，这些初步的实验表明磷脂酰肌醇-3-激酶抑制HIV-1转录的Tat依赖性机制。我们建议扩展这些研究，并使用细胞系，原代系统和生物化学方法，以1）进一步表征CD 28的差异信号在调节HIV-1转录中的作用，2）表征顺式元件和转录因子介导的LTR活性诱导响应CD 28信号和3）确定Nef是否直接或间接改变CD 28信号。了解CD 28调节HIV-1转录的机制将进一步确定与该受体相关的途径，并确定对控制HIV-1表达至关重要的推定上游信号转导事件。此外，操纵这些途径的能力可以为控制病毒表达提供独特的治疗靶点。 这项研究与公共卫生的相关性：我们建议确定和描述影响艾滋病毒产生的细胞事件。操纵这些细胞通路可能会提供新的策略，以补充目前的治疗，以控制艾滋病毒 以及清除潜在艾滋病毒储备者的方法。